Shopping Cart
- Remove All
Your shopping cart is currently empty
Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of α1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 1-2 weeks | |
| 50 mg | $1,980 | 1-2 weeks | |
| 100 mg | $2,500 | 1-2 weeks |
| Description | Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of α1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3]. |
| In vitro | Terazosin exhibits non-selective activity towards cloned α1-adrenoceptor subtypes transiently expressed in COS cells [1]. |
| In vivo | Terazosin facilitates the expulsion of ureteral stones, particularly effective for distal ureteral stones larger than 5 mm [3]. It is recognized as a safe and efficient option for this treatment. |
| Molecular Weight | 387.43 |
| Formula | C19H25N5O4 |
| Cas No. | 63590-64-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.